BioSpace News Archive

Business

Bristol Myers Squibb and AbbVie to Cut 360 Jobs Across CA

Both Bristol Myers Squibb and AbbVie filed a WARN notice with the California state government stating they intend to lay off up to 360 people.

September 19, 2022
·
2 min read
·
Mark Terry
Business

GENFIT Drops Up to $105M for Versantis to Up Liver Game

Genfit announced that it is Versantis for roughly $40 million cash and approximately $65 million in milestone payments and other considerations.

September 19, 2022
·
2 min read
·
Paul Elias
Drug Development

Research Ramps Up in Alzheimer’s, Parkinson’s, MS and ALS

Research on Alzheimer’s, specifically in neuroscience, continues with the Alzheimer’s Drug Discovery Foundation, Critical Path Institute, Abbvie, AlzeCure Pharma and more.

September 19, 2022
·
4 min read
·
Paul Elias
Drug Development

Clinical Catch-Up: Pfizer’s Pneumococcal in, Trevi’s Chronic Cough Drug and More

The past week saw promising developments in candidate therapies for cancer, congenital hyperinsulinism, chronic cough and COVID-19 vaccines.

September 19, 2022
·
5 min read
·
Vanessa Doctor, RN
FDA

Bluebird on a Roll with Second FDA Approval in Matter of Weeks

The FDA approved bluebird bio’s lentiviral vector (LVV) eli-cel Friday as the first therapy to slow the progression of neurologic dysfunction in juvenile boys with early, active CALD.

September 19, 2022
·
3 min read
·
Alex Keown
Drug Development

COVID-19 Variants Potential Factor in Mixed Virios Fibromyalgia Results

Virios Therapeutics announced Monday its lead asset IMC-1 fell short of its primary endpoint in the Phase IIb FORTRESS study in patients with fibromyalgia.

September 19, 2022
·
2 min read
·
Tristan Manalac
Drug Development

Nicox Announces Last Patients Complete Final Visit in NCX 470 Phase 3 Mont Blanc Glaucoma Trial

Nicox SA, an international ophthalmology company, announced that the last patients completed their final visit in the Mont Blanc Phase 3 clinical trial of NCX 470 0.1% for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

September 19, 2022
·
4 min read
BIOCORP announces the CE marking of SoloSmart®, an accessory medical device for SANOFI Solostar® pens at the occasion of EASD

BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices, and SANOFI announced the completion of the development of SoloSmart® , on the opening of the EASD annual meeting in Stockholm, Sweden.

September 19, 2022
·
2 min read
Genetown

Sage Therapeutics and Biogen Present New Analyses at Psych Congress Further Evaluating the Efficacy and Safety of Zuranolone

Sage Therapeutics, Inc. and Biogen Inc. announced new analyses from across the development program for zuranolone, an investigational, oral, once-daily, 14-day treatment in clinical development for adult patients with major depressive disorder and postpartum depression.

September 19, 2022
·
13 min read
Business

Mallinckrodt Announces Appointment of Lisa French as Chief Commercial Officer

Mallinckrodt plc, a global specialty pharmaceutical company, announced it has appointed Lisa French as Executive Vice President and Chief Commercial Officer, effective October 1, 2022.

September 19, 2022
·
5 min read